Literature DB >> 17625786

Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery.

Jolyon P Mitchell1, Mark W Nagel.   

Abstract

BACKGROUND: Valved holding chambers (VHCs) are prescribed with pressurised metered dose inhalers (pMDIs) to improve medication delivery for the treatment of respiratory diseases because they reduce the need for the patient to co-ordinate inhaler actuation with the onset of inhalation. Although mechanically robust and clinically effective if properly designed and pre-conditioned, there are several causes of inconsistent medication delivery if this is not the case. These include: electrostatic charge; incorrect operation of inhalation and exhalation valves; and the fit of the facemask - where present - to the face. In addition, behavioral factors, such as not following patient instructions for use and maintenance, and imperfect breathing technique, amplify overall variability. Aids such as valve movement indicators that provide patient feedback are helpful in order to minimise these factors.
METHODS: This article reviews recent literature concerning the causes of inconsistent drug delivery and the improvements that have been made by manufacturers to VHC devices, and assesses the clinical implications. The attributes of a well-designed VHC are summarised.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625786      PMCID: PMC6634215          DOI: 10.3132/pcrj.2007.00034

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  11 in total

Review 1.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

2.  Wheeze in childhood: is the spacer good enough?

Authors:  Veena Rajkumar; Barathi Rajendra; Choon How How; Seng Bin Ang
Journal:  Singapore Med J       Date:  2014-11       Impact factor: 1.858

3.  Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Authors:  Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-15

4.  Comparison of effectiveness and time-efficiency between multimedia and conventional counselling on metered-dose inhaler technique education.

Authors:  Teck Long King; Evelyn Kui Yee Kho; Yiek Hung Tiong; Siti Norhajariah Binti Julaihi
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

5.  Controller Inhalers: Overview of Devices, Instructions for Use, Errors, and Interventions to Improve Technique.

Authors:  Patrick K Gleeson; Scott Feldman; Andrea J Apter
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-12

Review 6.  Optimizing the Delivery of Inhaled Medication for Respiratory Patients: The Role of Valved Holding Chambers.

Authors:  R Andrew McIvor; Hollie M Devlin; Alan Kaplan
Journal:  Can Respir J       Date:  2018-04-04       Impact factor: 2.409

Review 7.  Spacer devices for inhaled therapy: why use them, and how?

Authors:  Walter Vincken; Mark L Levy; Jane Scullion; Omar S Usmani; P N Richard Dekhuijzen; Chris J Corrigan
Journal:  ERJ Open Res       Date:  2018-06-18

8.  Preference of diagnostic tools, medications, and devices for asthma management: A survey of doctors in Algeria.

Authors:  Jaideep Gogtay; Leila Laouar; Vaibhav Gaur
Journal:  Perspect Clin Res       Date:  2019 Apr-Jun

9.  The challenge of delivering therapeutic aerosols to asthma patients.

Authors:  Federico Lavorini
Journal:  ISRN Allergy       Date:  2013-08-05

Review 10.  Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Authors:  Mark L Levy; P N R Dekhuijzen; P J Barnes; M Broeders; C J Corrigan; B L Chawes; L Corbetta; J C Dubus; Th Hausen; F Lavorini; N Roche; J Sanchis; Omar S Usmani; J Viejo; W Vincken; Th Voshaar; G K Crompton; Soren Pedersen
Journal:  NPJ Prim Care Respir Med       Date:  2016-04-21       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.